2013-09-04 22:03:01 -
MENLO PARK, Calif., September 4, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that John Scarlett, M.D., President and Chief Executive Officer, will
present an overview of the company at 9:45 a.m. Eastern Time on Wednesday,
September 11, at the Stifel Nicolaus 2013 Healthcare Conference in Boston.
A live webcast of the presentation will be available at
Following the live presentation, the webcast will be archived and available for
replay at the same address for a period of 30 days.
Geron is a clinical stage biopharmaceutical company developing a first-in-class
telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more
information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Geron Corp. via Thomson Reuters ONE